Medpace Inc.

NASDAQ: MEDP · Real-Time Price · USD
304.75
2.50 (0.83%)
At close: May 02, 2025, 3:59 PM
306.00
0.41%
After-hours: May 02, 2025, 04:30 PM EDT
0.83%
Bid 300.33
Market Cap 8.76B
Revenue (ttm) 2.16B
Net Income (ttm) 416.39M
EPS (ttm) 13.09
PE Ratio (ttm) 23.28
Forward PE 22.08
Analyst Hold
Ask 306.5
Volume 255,372
Avg. Volume (20D) 509,690
Open 308.99
Previous Close 302.25
Day's Range 303.51 - 312.25
52-Week Range 250.05 - 459.77
Beta 1.46

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory...

Sector Healthcare
IPO Date Aug 11, 2016
Employees 5,900
Stock Exchange NASDAQ
Ticker Symbol MEDP
Full Company Profile

Analyst Forecast

According to 10 analyst ratings, the average rating for MEDP stock is "Hold." The 12-month stock price forecast is $333, which is an increase of 9.27% from the latest price.

Stock Forecasts
1 week ago
-2.32%
Medpace Holdings shares are trading lower. The com... Unlock content with Pro Subscription
1 week ago
-2.46%
Medpace Holdings shares are trading lower. The company reported Q1 financial results.